SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001654954-20-007958
Filing Date
2020-07-23
Accepted
2020-07-23 17:00:37
Documents
1
Effectiveness Date
2020-07-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 5587
  Complete submission text file 0001654954-20-007958.txt   7044
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-368883 | Film No.: 201044187
SIC: 2834 Pharmaceutical Preparations